Innovid Corp. WT (CTV-WT)
USD 0.11
(0.0%)
USD 0.11
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 12.44 Million | -11.56 Million | -5.63 Million | -4.15 Million | -8.98 Million |
| Net Income | -31.91 Million | -18.41 Million | -11.47 Million | -812 Thousand | -7.33 Million |
| Depreciation & Amortization | 10.74 Million | 6.14 Million | 661 Thousand | 730 Thousand | 431 Thousand |
| Deferred income taxes | -49.31 Million | - | - | 213 Thousand | 25 Thousand |
| Stock-based compensation | 20 Million | 13.78 Million | 3.27 Million | 584 Thousand | 378 Thousand |
| Change in working capital | 117 Thousand | 1.59 Million | 687 Thousand | -4.89 Million | -2.48 Million |
| Other non-cash items | 62.8 Million | -14.67 Million | 1.22 Million | 22 Thousand | -1000.00 |
| Investing Cash Flow | -479 Thousand | -119.42 Million | -3.22 Million | -948 Thousand | -6.22 Million |
| Investments in PPE | -10.31 Million | -10.44 Million | -3.14 Million | -1.03 Million | -1.65 Million |
| Acquisitions | -205 Thousand | -99.09 Million | - | 6000.00 | -4.23 Million |
| Investment purchases | -165 Thousand | -10 Million | - | - | - |
| Sales/Maturities of investments | 10 Million | 10 Million | - | - | - |
| Other Investing Activities | 205 Thousand | -9.88 Million | -85 Thousand | 75.99 Thousand | -333 Thousand |
| Financing Cash Flow | 794 Thousand | 11.8 Million | 149.92 Million | 9 Million | 23.79 Million |
| Debt repayment | -35 Million | -14 Million | -3.03 Million | -6.5 Million | -6 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 794 Thousand | 985 Thousand | 1.08 Million | 582 Thousand | - |
| Other Financing Activities | 35 Million | 24.81 Million | 151.87 Million | 14.92 Million | 29.79 Million |
| Accounts receivables | -2.76 Million | -4.04 Million | -618 Thousand | -8.37 Million | -5.17 Million |
| Accounts payables | -551 Thousand | -622 Thousand | 1.5 Million | -545 Thousand | 721 Thousand |
| Inventory | - | - | -1.43 Million | 2.1 Million | 393 Thousand |
| Other working capital | 3.43 Million | 6.26 Million | 1.23 Million | 1.91 Million | 1.57 Million |
| Cash at beginning of period | 37.54 Million | 157.15 Million | 16.09 Million | 12.19 Million | 3.61 Million |
| Cash at end of period | 49.58 Million | 37.97 Million | 157.15 Million | 16.09 Million | 12.19 Million |
| Capital Expenditure | -10.31 Million | -10.44 Million | -3.14 Million | -1.03 Million | -1.65 Million |
| Effect of forex changes on cash | -729 Thousand | - | - | - | - |
| Net cash flow / Change in cash | 12.04 Million | -119.18 Million | 141.06 Million | 3.89 Million | 8.58 Million |
| Free Cash Flow | 2.12 Million | -22.01 Million | -8.77 Million | -5.18 Million | -10.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.54 Million | -6.23 Million | -31.91 Million | -1.65 Million | -2.73 Million | -18.95 Million |
| Depreciation & Amortization | 2.83 Million | 2.62 Million | 10.74 Million | 4.18 Million | 4.71 Million | 2.06 Million |
| Deferred income taxes | - | - | -49.31 Million | -16.16 Million | - | - |
| Stock-based compensation | 5.18 Million | 3.83 Million | 20 Million | 4.53 Million | 5.6 Million | 5.33 Million |
| Change in working capital | 3.38 Million | 4.13 Million | 117 Thousand | -2.4 Million | -690 Thousand | -1.79 Million |
| Other non-cash items | 10.13 Million | 6.05 Million | 62.8 Million | 16.3 Million | -409 Thousand | 13.93 Million |
| Investing Cash Flow | -2.06 Million | -2.59 Million | -479 Thousand | -2.28 Million | -2.36 Million | -2.58 Million |
| Investments in PPE | -2.28 Million | -2.54 Million | -10.31 Million | -2.02 Million | -2.41 Million | -2.6 Million |
| Acquisitions | - | - | -205 Thousand | -1.00 | - | - |
| Investment purchases | 53 Thousand | -53 Thousand | -165 Thousand | -159.21 Thousand | - | - |
| Sales/Maturities of investments | 163.64 Thousand | - | 10 Million | -35.63 Thousand | -154.56 Thousand | -7000.00 |
| Other Investing Activities | -1.79 Million | -2.32 Million | 205 Thousand | -74.57 Thousand | 204.56 Thousand | 27 Thousand |
| Financing Cash Flow | 200.24 Thousand | -19.95 Million | 794 Thousand | 18.47 Thousand | 158 Thousand | 364 Thousand |
| Debt repayment | -163.9 Thousand | -20 Million | -35 Million | -15 Million | -10 Million | -5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 36.34 Thousand | 42.99 Thousand | 794 Thousand | 18.47 Thousand | 143.52 Thousand | 354.13 Thousand |
| Other Financing Activities | 37 Thousand | 43 Thousand | 35 Million | 15 Million | 10.01 Million | 5 Million |
| Accounts receivables | -3.95 Million | 4.6 Million | -2.76 Million | -2.76 Million | -321 Thousand | -3.29 Million |
| Accounts payables | 4.99 Million | -1.28 Million | -551 Thousand | -496.8 Thousand | -1.09 Million | -498 Thousand |
| Inventory | - | - | - | 1.00 | -239 Thousand | 893 Thousand |
| Other working capital | 2.34 Million | 806 Thousand | 3.43 Million | 855.51 Thousand | 966 Thousand | 1.1 Million |
| Cash at beginning of period | 31.57 Million | 49.58 Million | 37.54 Million | 47.68 Million | 43.78 Million | 45.41 Million |
| Cash at end of period | 30.58 Million | 31.57 Million | 49.58 Million | 49.58 Million | 48.06 Million | 43.78 Million |
| Capital Expenditure | -2.28 Million | -2.54 Million | -10.31 Million | -2.02 Million | -2.41 Million | -2.6 Million |
| Effect of forex changes on cash | -161 Thousand | -90 Thousand | -729 Thousand | -379.71 Thousand | -208 Thousand | - |
| Net cash flow / Change in cash | -994 Thousand | -18.01 Million | 12.04 Million | 1.9 Million | 4.28 Million | -1.63 Million |
| Free Cash Flow | -1.1 Million | 2.11 Million | 2.12 Million | 2.78 Million | 4.07 Million | -2.02 Million |
PFFEF
3391
1031
ROSEMER
003041
GUJINJEC